EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ROS‐Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling

Chenyang Ye iD, Mi Mi, Saimeng Shi, Lina Qi, Shanshan Weng, Lu Wang, Yier Lu, Chao Chen, Yinuo Tan, Mengyuan Yang, Cheng Guo, Rui Bai und 3 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202506599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chenyang Ye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, School of Medicine, Ministry of Education, Th…. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms, Tumor Microenvironment, STAT3 Transcription Factor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Start-up funding of Zhejiang Provincial People's Hospital, Basic Scientific Research Funds of Department of Education of Zhejiang Province, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting Nampt to modulate NAD + metabolism and exert antitumor effects has become a research hotspot in the field of cancer metabolism. But early clinical trials have only achieved modest results, primarily due to the need for improved efficacy and the occurrence of severe systemic adverse effects. Therefore, enhancing antitumor efficacy and reducing the adverse effects of Nampt inhibitors are urgent challenges. The research reveals that the Nampt inhibitor FK866 can induce ferroptosis in colorectal cancer cells via the NAD + /Stat3/Gpx4 signaling axis. Furthermore, the combination of FK866 and the Stat3 inhibitor C188‐9 demonstrates a strong synergistic antitumor effect. Importantly, a reactive oxygen species (ROS)‐responsive hydrogel that encapsulates FK866 and C188‐9 for in situ drug delivery, effectively reducing systemic side effects, is developed. Intriguingly, mass cytometry time‐of‐flight (CyTOF) analysis indicates that the combined treatment with FK866 and C188‐9 exerts antitumor effects by increasing the infiltration of CD8 + T cells and neutrophils into the tumor, as well as enhancing the expression of immune‐regulatory molecules, including IFN‐γ, IL‐10, and perforin. Thus, this localized treatment not only minimizes systemic adverse effects, but also markedly amplifies antitumor efficacy through the modulation of both tumor cells and the tumor immune microenvironment, representing a promising antitumor treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisColorectal NeoplasmsTumor MicroenvironmentSTAT3 Transcription FactorNicotinamide PhosphoribosyltransferaseReactive Oxygen SpeciesHydrogelsCytokinesAntineoplastic AgentsAnimalsMiceHumansDrug SynergismCell Line, TumorAcrylamidesPiperidines

Stichwörter der Autor:innen

FK866colorectal cancerferroptosisreactive oxygen species (ROS)‐responsive hydrogeltumor immune microenvironment

Substanzen

STAT3 Transcription FactorNicotinamide PhosphoribosyltransferaseReactive Oxygen SpeciesHydrogelsCytokinesSTAT3 protein, humanAcrylamidesAntineoplastic AgentsPiperidinesN-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, School of Medicine, Ministry of Education, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejian…
  • Center for Plastic & Reconstructive Surgery, Department of Plastic &Reconstructive, Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, 310014, P. R. China.
  • Department of Colorectal Surgery and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, Key Laboratory of Molecular Biology in Medical Sciences, China National Ministry of Education; Zhejiang Provin…
  • Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, 310009, China.

ORCID-Profile: Chenyang Ye, Ji Wang

Förderung

  • Start-up funding of Zhejiang Provincial People's Hospital
  • Basic Scientific Research Funds of Department of Education of Zhejiang Province
  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Ye, C., Mi, M., Shi, S., Qi, L., Weng, S., Wang, L., Lu, Y., Chen, C., Tan, Y., Yang, M., Guo, C., Bai, R., Fang, X., Wang, J., & Yuan, Y. (2025). ROS‐Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling. Advanced Science. https://doi.org/10.1002/advs.202506599

Vancouver

Ye C, Mi M, Shi S, Qi L, Weng S, Wang L, et al. ROS‐Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling. Advanced Science. 2025. doi:10.1002/advs.202506599

BibTeX
@article{Ye2025,
  author = {Ye, Chenyang and Mi, Mi and Shi, Saimeng and Qi, Lina and Weng, Shanshan and Wang, Lu and Lu, Yier and Chen, Chao and Tan, Yinuo and Yang, Mengyuan and Guo, Cheng and Bai, Rui and Fang, Xuefeng and Wang, Ji and Yuan, Ying},
  title = {ROS‐Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202506599}
}
Kostenlos starten →